PEXEVA®

Depression Is Real

Depression is more than feeling "blue" or "down in the dumps" every now and then. It is a serious medical condition that affects millions of people in different ways.

Depression can affect your mood, your body, and your thoughts for long periods of time. It can change how you feel about yourself and others, and how you go about daily living. For some, it means a loss of energy or the ability to concentrate. It can interfere with appetite and sleep habits, but with proper treatment, 4 out of 5 people will improve.

Some people experience depression during or after a major event in their lives. Depression can also be caused by changes in hormone levels. A person's family history may contribute to a risk of depression. Most of the time, a combination of factors leads to a depressive episode. Today, scientists believe that depression may be caused by an imbalance of certain chemicals in the brain that can influence a person's mood.

Depression often occurs with some form of anxiety.
Generalized anxiety disorder can make a person feel irritable or tense, unable to stop worrying. People with panic disorder may suddenly feel panicky, break into a sweat, and feel their heart pounding. Anxiety symptoms, either as part of depression or as a distinct disorder, such as generalized anxiety disorder or panic disorder, can make someone who is experiencing depression feel even worse.

The good news is that depression, generalized anxiety disorder, and panic disorder are treatable.
For people with these disorders, PEXEVA can help resolve symptoms like sadness, low energy, sleep distrubance, irritability, despair, excessive worry, becoming easily fatigued, sudden and intense fear, or an urge to escape from a situation.

Important Safety Information

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of PEXEVA® (paroxetine mesylate) or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. PEXEVA® (paroxetine mesylate) is not approved for use in pediatric patients. (See Warnings: Clinical Worsening and Suicide Risk, Precautions: Information for Patients, and Precautions: Pediatric Use)

All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.

Concomitant use of PEXEVA® (paroxetine mesylate) in patients taking monoamine oxidase inhibitors (MAOIs), thioridazine, or pimozide is contraindicated. If concomitant use of paroxetine with a 5-hydroxytryptamine receptor agonist (triptan) is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases. PEXEVA® (paroxetine mesylate) tablets are contraindicated in patients with a hypersensitivity to paroxetine or any of the inactive ingredients in PEXEVA® (paroxetine mesylate) tablets.

The most common side effects that have been reported with PEXEVA® include nausea, dry mouth, constipation, decreased appetite, infection, drowsiness, tremor, sweating, muscle weakness, trouble sleeping, abnormal ejaculation, impotence and other male genital disorders, and female genital disorders.

Please see Important Safety Information, including Black Boxed WARNING.

Please see accompanying full Prescribing Information including WARNINGS-Clinical Worsening and Suicide Risk; Usage in Pregnancy: Teratogenic and Nonteratogenic Effects.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


Copyright © 2010 Noven Therapeutics, LLC All rights reserved. For U.S. Audience Only
Visit Noven Therapeutics